Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories
Lene Holm Harritshøj, Mikkel Gybel‐Brask, Shoaib Afzal, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 5
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
Amir Massarweh, Noa Eliakim‐Raz, Amos Stemmer, et al.
JAMA Oncology (2021) Vol. 7, Iss. 8, pp. 1133-1133
Open Access | Times Cited: 275
Review of COVID-19 testing and diagnostic methods
Olena Filchakova, Dina Dossym, Aisha Ilyas, et al.
Talanta (2022) Vol. 244, pp. 123409-123409
Open Access | Times Cited: 178
Antibody tests for identification of current and past infection with SARS-CoV-2
Tilly Fox, Julia Geppert, Jacqueline Dinnes, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 177
Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept
Nathalie Chavarot, Amani Ouedrani, Olivier Marion, et al.
Transplantation (2021) Vol. 105, Iss. 9, pp. e94-e95
Open Access | Times Cited: 112
Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients
Sabina Herrera, Jordi Colmenero, Mariona Pascal, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 3971-3979
Open Access | Times Cited: 93
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
Nathalie Chavarot, Antoine Morel, Marianne Leruez‐Ville, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 4043-4051
Open Access | Times Cited: 93
SARS-CoV-2 in first trimester pregnancy: a cohort study
Nina la Cour Freiesleben, Pia Egerup, Kathrine Vauvert Römmelmayer Hviid, et al.
Human Reproduction (2020)
Open Access | Times Cited: 92
Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis
Christian Gytz Ammitzbøll, Lars Erik Bartels, J.B. Andersen, et al.
ACR Open Rheumatology (2021) Vol. 3, Iss. 9, pp. 622-628
Open Access | Times Cited: 80
Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre‐pandemic controls
Kiwook Jung, Sue Shin, Minjeong Nam, et al.
Journal of Clinical Laboratory Analysis (2021) Vol. 35, Iss. 9
Open Access | Times Cited: 65
Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents
Nina Koerber, Alina Priller, Sarah Yazici, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 58
Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study
Christian Erikstrup, Anna Laksafoss, Josephine Gladov, et al.
The Lancet Regional Health - Europe (2022) Vol. 21, pp. 100479-100479
Open Access | Times Cited: 50
Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico
Samuel Ponce‐de‐León, Martha Torres, Luis Enrique Soto-Ramírez, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 28
Rapid detection of SARS-CoV-2: The gradual boom of lateral flow immunoassay
Jing He, Shuying Zhu, Jiawei Zhou, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 10
Open Access | Times Cited: 25
The importance of using WHO International Standards to harmonise SARS-CoV-2 serological assays
Heidi Hempel, Mark Page, Troy J. Kemp, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 3, pp. e301-e305
Open Access | Times Cited: 8
Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study
Laura Espenhain, Siri Tribler, Charlotte Sværke Jørgensen, et al.
European Journal of Epidemiology (2021) Vol. 36, Iss. 7, pp. 715-725
Open Access | Times Cited: 47
Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain
Mario Poljak, Anja Oštrbenk Valenčak, Tina Štamol, et al.
Journal of Clinical Virology (2021) Vol. 137, pp. 104784-104784
Open Access | Times Cited: 40
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
Fioravante Capone, Matteo Lucchini, Elisabetta Ferraro, et al.
Neurotherapeutics (2021) Vol. 19, Iss. 1, pp. 325-333
Open Access | Times Cited: 40
Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study
Houda Amellal, Najlaa Assaid, Hicham Charoute, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0288557-e0288557
Open Access | Times Cited: 17
Waning of Anti-spike Antibodies in AZD1222 (ChAdOx1) Vaccinated Healthcare Providers: A Prospective Longitudinal Study
Sanjeeb Kumar Mishra, Subrat Kumar Pradhan, Sanghamitra Pati, et al.
Cureus (2021)
Open Access | Times Cited: 34
Time Since Rituximab Treatment Is Essential for Developing a Humoral Response to COVID-19 mRNA Vaccines in Patients With Rheumatic Diseases
Anne Troldborg, Marianne Kragh Thomsen, Lars Erik Bartels, et al.
The Journal of Rheumatology (2022) Vol. 49, Iss. 6, pp. 644-649
Open Access | Times Cited: 26
Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico
Samuel Ponce‐de‐León, Martha Torres, Luis Enrique Soto-Ramírez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 24
Transplacental transfer of SARS-CoV-2 antibodies: a cohort study
Stine Yde Nielsen, Lars Henning Petersen, May Murra, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 42, Iss. 3, pp. 277-285
Open Access | Times Cited: 13
Maternal-Fetal Outcomes and Antibody Transfer, Depending on the Trimester of SARS-CoV-2 Infection in Non-Vaccinated Women—A Danish Nationwide Prospective Cohort Study
Line Fich, Ann-Marie Hellerung Christiansen, Kathrine Vauvert Römmelmayer Hviid, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2533-2533
Open Access
Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19
Zirui Meng, Shuo Guo, Yanbing Zhou, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 30
SARS‐CoV‐2 infection in pregnancy in Denmark—characteristics and outcomes after confirmed infection in pregnancy: A nationwide, prospective, population‐based cohort study
Anna J. M. Aabakke, Lone Krebs, Tanja Gram Petersen, et al.
Acta Obstetricia Et Gynecologica Scandinavica (2021) Vol. 100, Iss. 11, pp. 2097-2110
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top